SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-13.93%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
Cap. Flow
-$2.26M
Cap. Flow %
-1.56%
Top 10 Hldgs %
75.3%
Holding
32
New
2
Increased
13
Reduced
8
Closed
7

Top Buys

1
BDSI
BioDelivery Sciences International, Inc.
BDSI
$5.7M
2
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$2.72M
3
LGND icon
Ligand Pharmaceuticals
LGND
$2M
4
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.39M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
$1.15M

Top Sells

1
EBS icon
Emergent Biosolutions
EBS
$2.36M
2
CPIX icon
Cumberland Pharmaceuticals
CPIX
$2.1M
3
CHMA
Chiasma, Inc. Common Stock
CHMA
$1.56M
4
VSTM icon
Verastem
VSTM
$1.48M
5
MTNB icon
Matinas BioPharma
MTNB
$1.15M

Sector Composition

1 Healthcare 93.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$3.15B
$19.1M 13.16%
167,487
+17,487
+12% +$2M
VNDA icon
2
Vanda Pharmaceuticals
VNDA
$279M
$18.9M 13.02%
1,341,943
+81,655
+6% +$1.15M
AMRN
3
Amarin Corp
AMRN
$311M
$18M 12.42%
930,604
-15,775
-2% -$306K
BDSI
4
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$12.9M 8.85%
2,764,475
+1,225,038
+80% +$5.7M
ADMS
5
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$8.83M 6.08%
1,423,578
+439,249
+45% +$2.72M
APEN
6
DELISTED
Apollo Endosurgery, Inc.
APEN
$8.39M 5.77%
2,580,518
– –
NEOS
7
DELISTED
Neos Therapeutics, Inc
NEOS
$6.41M 4.42%
4,971,014
+459,510
+10% +$593K
ALIM
8
DELISTED
Alimera Sciences, Inc.
ALIM
$5.73M 3.95%
6,439,498
-44,112
-0.7% -$39.3K
CPIX icon
9
Cumberland Pharmaceuticals
CPIX
$52.2M
$5.55M 3.82%
871,762
-330,213
-27% -$2.1M
ENTA icon
10
Enanta Pharmaceuticals
ENTA
$180M
$5.53M 3.8%
65,484
+4,644
+8% +$392K
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.35M 3.68%
4,113,522
+38,578
+0.9% +$50.2K
HTGM
12
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$4.62M 3.18%
2,785,585
-50,201
-2% -$83.3K
OPNT
13
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$4.18M 2.88%
315,468
+20,574
+7% +$273K
XOMA icon
14
Xoma
XOMA
$392M
$4.02M 2.77%
270,449
+43,019
+19% +$639K
APVO icon
15
Aptevo Therapeutics
APVO
$5.39M
$3.48M 2.39%
3,922,891
+28,672
+0.7% +$25.4K
CTIC
16
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.36M 2.31%
3,904,400
-95,600
-2% -$82.1K
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.14M 2.16%
227,900
+100,676
+79% +$1.39M
AFMD
18
DELISTED
Affimed
AFMD
$2.05M 1.41%
715,754
+210,018
+42% +$603K
FOMX
19
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.55M 1.07%
651,211
-78,793
-11% -$188K
VIVE
20
DELISTED
VIVEVE MED INC
VIVE
$1.29M 0.89%
3,403,402
– –
IDXG
21
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1.27M 0.88%
1,753,184
+319,154
+22% +$231K
MTNB icon
22
Matinas BioPharma
MTNB
$10.1M
$573K 0.39%
668,615
-1,339,391
-67% -$1.15M
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
$508K 0.35%
162,244
-24,830
-13% -$77.7K
NVLN
24
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$383K 0.26%
+491,096
New +$383K
MOTS
25
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$107K 0.07%
+35,205
New +$107K
1
2